Consumer Staples Sector Faces Significant Challenges
Written by Emily J. Thompson, Senior Investment Analyst
Updated: 8 hours ago
0mins
Should l Buy CL?
Source: Fool
- Poor Market Performance: Over the past month, the Consumer Staples Select SPDR ETF (XLP) has declined nearly 8%, contradicting the sector's defensive profile and disappointing investors, particularly amid concerning economic data and U.S. military involvement.
- Colgate's Stock Decline: Colgate-Palmolive (CL) has dropped 13.6% in the last month, indicating a correction and behaving more like a high-risk growth stock than a traditional dividend payer, which may present a buying opportunity for investors.
- Rising Raw Material Costs: Colgate faces rising raw material prices, and while companies typically pass some costs onto consumers, the surge in oil prices due to the Iran conflict may lead consumers to seek cheaper alternatives, impacting sales.
- Brand Loyalty and Cash Flow: Despite challenges, Colgate maintains brand loyalty in fast-growing markets like Brazil, China, and India, and reported record operating cash flow of $4.2 billion last year, indicating long-term stability, while its safe dividend further reassures investors.
Trade with 70% Backtested Accuracy
Stop guessing "Should I Buy CL?" and start using high-conviction signals backed by rigorous historical data.
Sign up today to access powerful investing tools and make smarter, data-driven decisions.
Analyst Views on CL
Wall Street analysts forecast CL stock price to rise
15 Analyst Rating
10 Buy
4 Hold
1 Sell
Moderate Buy
Current: 85.730
Low
77.00
Averages
87.79
High
95.00
Current: 85.730
Low
77.00
Averages
87.79
High
95.00
About CL
Colgate-Palmolive Company is a growth company. It is focused on Oral Care, Personal Care, Home Care and Pet Nutrition, it sells its products under brands, such as Colgate, Palmolive, elmex, hello, meridol, Sorriso, Tom's of Maine, EltaMD, Filorga, Irish Spring, Lady Speed Stick, PCA SKIN, Protex, Sanex, Softsoap, Speed Stick, Ajax, Axion, Fabuloso, Murphy, Soupline and Suavitel, as well as Hill's Science Diet and Hill's Prescription Diet. Its Oral, Personal and Home Care product segment is managed geographically in five segments, such as North America, Latin America, Europe, Asia Pacific and Africa/Eurasia, all of which sell primarily to a variety of traditional and e-commerce retailers, wholesalers, distributors, dentists and skin health professionals. Its Pet Nutrition products include specialty pet nutrition products manufactured and marketed by Hill's Pet Nutrition. The customers for Pet Nutrition products are authorized pet supply retailers, veterinarians and e-commerce retailers.
About the author

Emily J. Thompson
Emily J. Thompson, a Chartered Financial Analyst (CFA) with 12 years in investment research, graduated with honors from the Wharton School. Specializing in industrial and technology stocks, she provides in-depth analysis for Intellectia’s earnings and market brief reports.
- Market Sentiment Improves: The S&P 500 index rose by 1.02%, the Dow Jones Industrial Average increased by 0.67%, and the Nasdaq 100 surged by 1.10% as President Trump signaled a willingness to end military actions against Iran, reflecting investor optimism over easing geopolitical risks.
- Falling Bond Yields: The 10-year Treasury note yield dropped to a one-week low of 4.30%, indicating market expectations that an end to the Iran conflict could lower energy prices and alleviate inflation concerns, further supporting stock market gains.
- Consumer Confidence Rises: The US March consumer confidence index unexpectedly increased by 0.8 to 91.8, surpassing expectations of a decline to 87.9, suggesting enhanced consumer confidence in economic prospects, which could drive spending and economic growth.
- Strong Chinese Economy: China's March manufacturing PMI rose to 50.4, exceeding expectations of 50.1, indicating signs of economic recovery that support global growth prospects and positively influence market performance.
See More
- Market Rebound: The S&P 500 Index rose by 1.33%, the Dow Jones Industrial Average increased by 1.10%, and the Nasdaq 100 Index climbed by 1.45%, reflecting investor optimism following President Trump's willingness to end military actions against Iran, potentially easing geopolitical tensions.
- Supportive Economic Data: China's March manufacturing PMI rose by 1.4 to 50.4, surpassing expectations of 50.1, indicating signs of economic recovery that could enhance global growth prospects and drive stock markets higher.
- Falling Bond Yields: The 10-year T-note yield dropped to 4.30%, a one-week low, as WTI crude oil prices fell, alleviating inflation concerns and lowering borrowing costs, thereby supporting further gains in the stock market.
- Tech Stocks Lead Gains: The
See More
- Poor Market Performance: Over the past month, the Consumer Staples Select SPDR ETF (XLP) has declined nearly 8%, contradicting the sector's defensive profile and disappointing investors, particularly amid concerning economic data and U.S. military involvement.
- Colgate's Stock Decline: Colgate-Palmolive (CL) has dropped 13.6% in the last month, indicating a correction and behaving more like a high-risk growth stock than a traditional dividend payer, which may present a buying opportunity for investors.
- Rising Raw Material Costs: Colgate faces rising raw material prices, and while companies typically pass some costs onto consumers, the surge in oil prices due to the Iran conflict may lead consumers to seek cheaper alternatives, impacting sales.
- Brand Loyalty and Cash Flow: Despite challenges, Colgate maintains brand loyalty in fast-growing markets like Brazil, China, and India, and reported record operating cash flow of $4.2 billion last year, indicating long-term stability, while its safe dividend further reassures investors.
See More
- Trump's Comments Impact: Trump's statement about serious discussions with Iran led to a rise in the S&P 500, but Jim Cramer cautioned investors against rushing to buy, as Trump's claims are often later denied by Iran, indicating market uncertainty.
- Meta Stock Surge: Meta was named a top pick by Morgan Stanley, with shares rising over 2%, as analysts argue that despite AI investment and regulatory risks, Meta remains competitively strong; Jim Cramer supports this view, suggesting investors should not sell due to regulatory concerns.
- Cybersecurity Stock Rebound: CrowdStrike and Palo Alto Networks rebounded after significant declines last Friday, with CrowdStrike up nearly 5% following an upgrade to buy-equivalent by Wolfe Research, as analysts believe advancements in AI models will increase demand for cybersecurity.
- Executive Buy Signal: Palo Alto Networks CEO Nikesh Arora purchased about $10 million in shares on Friday, resulting in a 7% stock increase, with Jim Cramer noting that the market is mispricing the stock, reflecting executive confidence in the company's future.
See More
- Market Opening Outlook: The S&P 500 is set for a higher open as President Trump signals progress in U.S.-Iran war talks, reflecting investor optimism despite typically rising oil prices dragging down stocks, indicating a potential shift in market sentiment.
- S&P 500 Performance Review: The S&P 500 has faced nearly a 6% decline in March, marking its fifth consecutive weekly loss, yet it narrowly avoids entering correction territory, with upcoming job reports expected to provide insights into economic health.
- Meta Platforms Investment Advice: Morgan Stanley recommends buying Meta Platforms, asserting that sentiment has bottomed out, and despite the company facing two litigation losses last week that impacted stock prices, early trading shows a slight recovery, indicating renewed investor confidence.
- Oracle's Positive Outlook: Bernstein analysts view Oracle's cloud and database sectors as potential AI winners, setting a price target of $319, which is more than double Friday's closing price of nearly $140, reflecting strong market confidence in its growth prospects.
See More
Colgate-Palmolive Shares Performance: Colgate-Palmolive's shares have increased by 1% following a positive upgrade from Deutsche Bank.
Deutsche Bank's Upgrade: Deutsche Bank has upgraded Colgate-Palmolive's stock rating to 'Buy', indicating a favorable outlook for the company's performance.
See More










